BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Pharm Country

  With Evidence of Efficacy, South Africa to Test J&J Vaccine on Health Care Workers

  South Africa recently announced it was halting distribution of the AstraZeneca-University of Oxford COVID-19 vaccine after data suggested it “provides minimal protection” against mild disease from the South African variant.

  February 10, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  AbbVie, Caribou Biosciences Collaborate in $40 Million CAR-T Cell Deal

  AbbVie committed up to another $300 in potential milestone payments.

  February 10, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  FDA

  Eli Lilly’s Antibody Combo Wins FDA Approval for Mild to Moderate COVID-19

  This combination therapy has been authorized for the treatment of mild to moderate COVID-19 in patients aged 12 and older who are at high risk for progressing to severe COVID-19 and/or hospitalization.

  February 10, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  WHO Wuhan Report Suggests Animal Origin for COVID-19 Virus

  The origins of COVID-19 continue to be debated in the halls of government, and the findings from a recent investigation conducted by the World Health Organization are unlikely to change many minds as the world continues to grapple with the pandemic.

  February 10, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Gilead’s O’Day’s Gamble on Galapagos is Facing Headwinds

  Belgium-based Galapagos NV and Foster City, California-based Gilead Sciences halted the ISABELA Phase III clinical trial of ziritaxestat in idiopathic pulmonary fibrosis.

  February 10, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  FDA Adcom Gives Merck’s Keytruda a Surprise Thumbs Down

  The U.S. FDA Oncologic Drugs Advisory Committee voted against recommending the drug as neoadjuvant treatment for high-risk, early-stage triple-negative breast cancer (TNBC) in combination with chemotherapy after surgery, at least for now.

  February 10, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Genetown

  Adicet Bio Prices Public Offering of Common Stock at $135 Million

  Adicet Bio announced pricing of an underwritten public offering of 9,230,770 shares of its common stock, marking it at a public offering per-share price of $13.00.

  February 10, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  Notch Soars Out of the Gate with $85 Million; Two More Follow Closely Behind

  There have been a few life sciences companies that have been attracting attention this week with strong Series A rounds.

  February 10, 2021

   · 

  2 min read

   · 

  Mark Zipkin
• 

  BioSpace Global Roundup: Rolling Submission for Sputnik V Begins in Europe

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

  February 10, 2021

   · 

  6 min read

   · 

  Alex Keown
• 

  PacBio Secures $900 Million Investment to Support Gene Sequencing

  Shares of Pacific Biosciences soared more than 21% in premarket trading after it was announced SB Management, a subsidiary of SoftBank Group Corp., will make an investment of $900 million into the company to support its gene sequencing research.

  February 10, 2021

   · 

  4 min read

   · 

  Alex Keown